Home › Funds › SATOVSKY ASSET MANAGEMENT LLC › DRTS
SATOVSKY ASSET MANAGEMENT LLC position in DRTS
ALPHA TAU MEDICAL LTD · Health Care
SATOVSKY ASSET MANAGEMENT LLC reported holding 36,636 shares of DRTS (ALPHA TAU MEDICAL LTD) in its Q2 2026 13F filing — a position valued at US$461K, representing 0.07% of its reported portfolio and ranking #39 among its reported holdings. SATOVSKY ASSET MANAGEMENT LLC has disclosed DRTS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SATOVSKY ASSET MANAGEMENT LLC's DRTS position evolved
SATOVSKY ASSET MANAGEMENT LLC first disclosed a stake in DRTS in Q4 2023 at 58,430 shares (US$176K). The position peaked in Q2 2026 at 36,636 shares, worth US$461K. Across 11 filings, SATOVSKY ASSET MANAGEMENT LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 36,636 shares valued at US$461K — a reduction of -4,070 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 58.43K | $175.87K | New |
| Q1 2024 | 48.59K | $143.35K | Reduce |
| Q2 2024 | 53.61K | $135.62K | Add |
| Q3 2024 | 53.61K | $127.58K | Hold |
| Q4 2024 | 53.61K | $166.18K | Hold |
| Q1 2025 | 53.61K | $134.55K | Hold |
| Q2 2025 | 53.61K | $167.25K | Hold |
| Q3 2025 | 53.61K | $241.76K | Hold |
| Q4 2025 | 53.61K | $265.35K | Hold |
| Q1 2026 | 40.71K | $287.79K | Reduce |
| Q2 2026 | 36.64K | $460.88K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DRTS and 13F data
DRTS (ALPHA TAU MEDICAL LTD) is a Health Care company. 62 other funds we track also report a position in DRTS — the largest reported positions include Gem Investment Advisors, LLC (US$18.0M), Aquamarine Financial (Cayman) Ltd (US$9.1M), Pier Capital, LLC (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DRTS
- Gem Investment Advisors, LLC 1.43M sh · $18.05M · Q2 2026
- Aquamarine Financial (Cayman) Ltd 721.50K sh · $9.08M · Q2 2026
- Pier Capital, LLC 691.94K sh · $8.70M · Q2 2026
- Daytona Street Capital LLC 120.84K sh · $1.80M · Q3 2026
- Dauntless Investment Group, LLC 61.20K sh · $769.90K · Q2 2026
More on SATOVSKY ASSET MANAGEMENT LLC
FAQ
How long has SATOVSKY ASSET MANAGEMENT LLC held DRTS?
SATOVSKY ASSET MANAGEMENT LLC has disclosed DRTS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is SATOVSKY ASSET MANAGEMENT LLC's current position in DRTS?
As of Q2 2026, SATOVSKY ASSET MANAGEMENT LLC holds 36.64K shares of DRTS (ALPHA TAU MEDICAL LTD), valued at $460.88K, representing 0.07% of its reported portfolio and ranking #39.
Has SATOVSKY ASSET MANAGEMENT LLC been buying or selling DRTS?
In the latest 13F filing (Q2 2026), SATOVSKY ASSET MANAGEMENT LLC reduced its position in DRTS. The position peaked in Q2 2026 at 36.64K shares.
Which other funds hold DRTS?
Other major institutional holders of DRTS include Gem Investment Advisors, LLC, Aquamarine Financial (Cayman) Ltd, Pier Capital, LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.